Rights and permissions
About this article
Cite this article
Palivizumab: a performer for prevention of RSV in Austria. Pharmacoecon. Outcomes News 640, 7 (2011). https://doi.org/10.2165/00151234-201106400-00021
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106400-00021